Effect of the Standardized Management of Cancer Pain on Patients with Bone Metastasis of Lung Cancer in China
Authors Jin JJ, Xu TT, Li YF, Wang HY, Zhang D, Zhang PP, Xu LX, Wang CX, Fan Z, Wang L, Liu C, Wang S, Shi HT, Li CH, Zhang HF, Huang Y
Received 9 December 2019
Accepted for publication 26 May 2020
Published 17 July 2020 Volume 2020:12 Pages 5903—5907
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Beicheng Sun
Jing-Jing Jin,1 Tian-Tian Xu,1 Yan-Fang Li,2 Hong-Yang Wang,1 Dan Zhang,1 Pan-Pan Zhang,1 Li-Xin Xu,1 Chun-Xiu Wang,1 Zhu Fan,1 Ling Wang,1 Chen Liu,1 Shuang Wang,1 Hao-Tian Shi,1 Cai-Hong Li,1 Hai-Fang Zhang,1 Yan Huang1
1Department of Respiratory Medicine, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, People’s Republic of China; 2Department of Pediatric Medicine, Hebei People’s Hospital Affiliated to North China University of Science and Technology, Shijiazhuang, Hebei 050000, People’s Republic of China
Correspondence: Yan Huang
Department of Respiratory Medicine, North China University of Science and Technology Affiliated Hospital, No. 73 of Jianshe Road, Lubei District, Tangshan, Hebei 063000, People’s Republic of China
Tel +86 18713877946
Objective: This study investigates the effect of the standardized management of cancer pain on patients with bone metastasis of lung cancer in China.
Patients and Methods: A total of 123 patients with bone metastasis of lung cancer were selected from the Respiratory Department of the Affiliated Hospital of North China University of Science and Technology. Among these patients, 62 patients who had not received standardized management of cancer pain from March 12, 2018, to September 11, 2018, were selected as the control group. In contrast, 61 patients who had received the standardized management of cancer pain from September 12, 2018, to March 11, 2019, were selected as the observation group. The former cohort accepted the conventional management of cancer pain, while the latter accepted the strict, standardized management of cancer pain. The demographic statistics, disease characteristics, and painkiller application of patients in these two groups were analyzed. Then, the analgesic effect and level of satisfaction were compared between these two groups.
Results: No significant differences were noticed between these two groups in terms of age, gender, smoking status, type of pathology, education level, previous treatment, and the Eastern Cooperative Oncology Group score, as well as other demographic and disease characteristics. As for the use of painkillers, opioid analgesics accounted for a higher proportion in the observation group than in the control group. Compared with the control group, pain improvement and patient satisfaction after analgesic treatment were significantly higher in the observation group (p < 0.05).
Conclusion: The standardized management of cancer pain can considerably alleviate the pain of patients with bone metastasis of lung cancer and improve their quality of life. Furthermore, this type of management can increase satisfaction.
Keywords: standard management, lung cancer, cancer pain, bone metastasis, analgesic effect
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]